Objective To investigate the factors influencing the survival time of patients with recurrent glioma after reoperation.Methods 45 cases in our hospital due to recurrence cerebral glioma undergoing reoperation were selected, whose general data were retrospective analyzed, and the surgery conditions, postoperative complications, survival time and its influencing factors were analyzed.Results In 45 cases of recurrent cerebral glioma patients undergoing surgical treatment, 25 cases with total resection, 20 cases with subtotal resection, 3 cases with postoperative brain edema, 3 cases with pulmonary infection; and compared with pre-surgery, the Karnovsky performance status (KPS) score increased significantly (P <0.05); and postoperative survival time was ( 10.62 ±3.25 ) months, multi-factor regression analysis showed that recurrence lesion resection, preoperative KPS score, recurrent interval time and preoperative grading is the independent risk factors related to survival time(P<0.05).Conclusion Surgical treatment of recurrent cerebral glioma is of great significance, and aggressive surgical treatment could improve the quality of life, prolong the survival time and improve the quality of life.

【Objective】 To investigate the management of adverse reactions to blood donation(ARBD) in blood services, so as to promote the surveillance of ARBD and improve the quality of blood donation service in Chongqing. 【Methods】 A questionnaire, involving the staff and facilities in blood donation sites as well as the prevention and treatment, the record and report, the following up and data related to ARBD was developed by Chongqing Society of Blood Transfusion in February 2019, and was issued to 18 blood services(1 blood center and its sub-center, 6 central blood stations and 11 hospital blood banks) in the Chongqing via email. The questionnaire was filled in and submitted before March 31 by management personnel participating in the investigation, and the data was collected, collated, revised and analyzed by Excel 2011. 【Results】 A total 19 questionnaires were collected, with the valid rate at 100%(19/19). 78.95%(15/19) of the blood services met the requirements of medical personnel allocation(>6 medical staff) when the number of daily blood collection was more than 60, and 100%(19/19)met the requirements of medical personnel allocation(2 to 6 medical staff) when the number of daily blood collection was less than 60. 89.47%(17/19) of the blood services were equipped with epinephrine hydrochloride, and 84.21%(16/19) with dexamethasone(an anti-allergic drug). There were significant differences in the allocation of other types of drugs. 100.00%(19/19) of the blood services formulated prevention and treatment measures concerning ARBD. In 2019, the incidence of ARBD in Chongqing was reported to be 0.54%(1 958 / 359 871), with the highestas [1.35%(223/16 543)] in subcenters and the lowest [0.32%(179/56 299)] in central blood centers (P<0.05). There was statistical significances in the incidences of ARBD reported by different blood stations(P<0.05). 【Conclusion】 The monitoring and management of ARBD among blood services in Chongqing should be further standardized in terms of staffing allocation, emergency drugs allocation and reporting, so as to gradually realize regional homogenization and ensure blood safety.